![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 38/50 | (2006.01) |
A61K 47/60 | (2017.08) | ||
A61K 47/60 | (2017.01) | ||
A61K 38/50 | (2013.01) | ||
A61P 35/00 | (2006.01) | ||
A61K 45/06 | (2013.01) | ||
A61K 45/06 | (2006.01) | ||
C12N 9/78 | (2013.01) | ||
C12N 9/78 | (2006.01) | ||
C12Y 305/03006 | (2013.01) | ||
A61P 35/02 | (2006.01) | ||
A61P 35/00 | (2018.01) | ||
A61P 35/02 | (2018.01) |
(11) | Number of the document | 3193913 |
(13) | Kind of document | T |
(96) | European patent application number | 15842576.9 |
Date of filing the European patent application | 2015-09-16 | |
(97) | Date of publication of the European application | 2017-07-26 |
(45) | Date of publication and mention of the grant of the patent | 2022-05-11 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2015/050354 |
Date | 2015-09-16 |
(87) | Number | WO 2016/044376 |
Date | 2016-03-24 |
(30) | Number | Date | Country code |
201462051182 P | 2014-09-16 | US |
(72) |
SHOWALTER, Richard , US
ALMASSY, Robert , US
THOMSON, James A. , US
SISSON, Wes , US
SHIA, Wei-Jong , US
CHEN, Li-Chang , US
LEE, Yang , US
|
(73) |
Polaris Group ,
P.O. Box 309
Ugland House, Grand Cayman, KY1-1104,
KY
|
(54) | ARGININE DEIMINASE WITH REDUCED CROSS-REACTIVITY TOWARD ADI - PEG 20 ANTIBODIES FOR CANCER TREATMENT |
ARGININE DEIMINASE WITH REDUCED CROSS-REACTIVITY TOWARD ADI - PEG 20 ANTIBODIES FOR CANCER TREATMENT |